ADVB earnings date and last-quarter result: P/E -57.51. Updated 2026-07-23.
Advanced Biomed Inc. Common Stock (ADVB) Research Hub
Advanced Biomed Inc. Common Stock (ADVB) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 2.73 USD (-13.88%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -57.51, market cap 0.02B. This hub links to the full technical, earnings and options research available for ADVB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.73 USD (-13.88%) |
| 52-week range | 2.73 USD – 24.23 USD |
| Trend regime | Range |
| 14-day RSI | 4.5 (Oversold) |
| Trailing P/E | -57.51 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for ADVB
Covered Call on ADVB: how it works, illustrative setup around the real 2.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ADVB: how it works, illustrative setup around the real 2.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ADVB: how it works, illustrative setup around the real 2.73 USD price, max profit/loss, breakeven and when to use it. Educational.
ADVB technical analysis: range, last 2.73 USD, RSI 4.5, 52w range 2.73 USD–24.23 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ADVB in?
Advanced Biomed Inc. Common Stock (ADVB) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is ADVB in an uptrend or downtrend?
As of 2026-10-26, ADVB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ADVB's trailing P/E ratio?
ADVB's trailing P/E is -57.51, with a market cap of 0.02B. See the earnings research page for full valuation detail.